Experts recommend SGLT-2 and GLP-1 diabetes drugs only for adults at moderate to higher risk of heart and kidney problems
Recommendations account for varied patient risk profiles and focus on weight loss effects, particularly of drugs of interest to adults with concomitant obesity SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher risk of cardiovascular and kidney ...

